Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
about
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancerThoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.Anal squamous cell carcinoma: an evolution in disease and management.Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsPredicting outcomes in radiation oncology--multifactorial decision support systemsComparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study.Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal.Anal cancer: are we making progress?Anal cancer: current standards in care and recent changes in practice.Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529Advances in the Management of Anal Cancer.Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.Psychiatric Care of the Radiation Oncology Patient.Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.[No improvement in survival with induction chemotherapy prior to chemotherapy in locally advanced head and neck cancer: Results of a randomised phase 3 trial (PARADIGM)].Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report.Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma.Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational studyImpact of intensity modulated radiation therapy on survival in anal cancer
P2860
Q30415832-20D34A81-18F1-4F8E-B20D-4BD4504AB3D1Q33397995-4228CB1A-965E-44FE-AC4B-9B6E413D3477Q33428648-F234AE06-2A86-4A30-89A1-7D63876884D5Q34183486-F515BDDE-4713-4B69-AA35-77C3BDD5098CQ34255528-A1FF73C5-A4A4-45A6-8290-9DD92B1705FBQ35879804-C7173D7E-DF25-4D39-A318-40E8C312A79CQ36009950-ECC3EC2D-1E49-4EE4-941E-7D899A3BC20DQ36014711-3371822D-26E6-488D-AF28-E387E9F23C58Q36062623-AC4CE38D-8523-41CD-8DA0-AFB9D3711766Q36242803-70247A25-AEF6-46F9-A30B-22A77DD45B62Q36621336-51B8746B-9E90-49C0-80D2-ED4371E5E965Q36786775-6320CBEE-DB14-489F-A976-477C300B572FQ36907276-7B712710-05AF-40C0-894E-7B0935877269Q38078283-C3EF7290-3F77-4B65-8400-9611241DC7BCQ38315952-50051FDD-ECC7-42C6-B182-3B3D5F81C025Q38399664-6A7FBC37-C88E-4685-B1EB-8C8163909DCEQ38746232-5E770F48-0524-47FF-844E-C8227A024579Q38785099-E1A7303F-4195-476B-824A-7FD006B7A32AQ39362898-4EBED343-E5EB-4892-909B-5CD6BA5C499CQ40909528-530D67EA-7137-4BA0-ACD1-6F4BAAA4BFC8Q41312134-3F35C6BD-59C8-42F6-B396-1ABDE51F70E0Q44468804-982A1474-0617-44CE-A698-DF5F6E2B5FB3Q49417105-4700F3B0-A229-4CAE-9F65-7C6BBFF3119DQ49537835-3A0C7975-207F-48C9-A668-BDEB6A00E7F6Q49713310-2887FD3E-A05C-4149-8081-F189A546F31BQ55103310-DF33AA42-46D5-4367-B849-05768D92FFDFQ58755495-A7D0B1DE-68BC-481F-A0E5-3A836CC5232DQ58806082-C13A1618-43C8-4EBB-87FE-A387402E51B7
P2860
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@ast
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@en
type
label
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@ast
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@en
prefLabel
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@ast
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@en
P2093
P2860
P356
P1476
Impact of overall treatment ti ...... Group trials 87-04 and 98-11.
@en
P2093
Christopher Willett
Jaffer A Ajani
Jennifer Moughan
JonDavid Pollock
Leonard Gunderson
Marshall Flam
Robert Myerson
Seth A Rosenthal
P2860
P304
P356
10.1200/JCO.2010.29.1351
P407
P577
2010-10-18T00:00:00Z